% alzhub.org library filter
% Source: https://alzhub.org/research?author=Blennow+K&about=genetics
% 29 entries, in the order the page lists them. Built from alzhub.org's own records.
% 0 entries have no readable author in the source record and carry no author field.

@article{salloway2014-24450891,
  author  = {Salloway, S. and Sperling, R. and Fox, N. C. and Blennow, K. and Klunk, W. and Raskind, M. and Sabbagh, M. and Honig, L. S. and others},
  title   = {{Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease}},
  journal = {The New England journal of medicine},
  year    = {2014},
  doi     = {10.1056/nejmoa1304839},
  pmid    = {24450891},
  url     = {https://doi.org/10.1056/nejmoa1304839}
}

@article{darst2017-27662287,
  author  = {Darst, B. F. and Koscik, R. L. and Racine, A. M. and Oh, J. M. and Krause, R. A. and Carlsson, C. M. and Zetterberg, H. and Blennow, K. and others},
  title   = {{Pathway-Specific Polygenic Risk Scores as Predictors of Amyloid-β Deposition and Cognitive Function in a Sample at Increased Risk for Alzheimer's Disease}},
  journal = {Journal of Alzheimer's disease : JAD},
  year    = {2017},
  doi     = {10.3233/jad-160195},
  pmid    = {27662287},
  url     = {https://doi.org/10.3233/jad-160195}
}

@article{johansson2023-36626935,
  author  = {Johansson, C. and Thordardottir, S. and Laffita-Mesa, J. and Rodriguez-Vieitez, E. and Zetterberg, H. and Blennow, K. and Graff, C.},
  title   = {{Plasma biomarker profiles in autosomal dominant Alzheimer's disease}},
  journal = {Brain : a journal of neurology},
  year    = {2023},
  doi     = {10.1093/brain/awac399},
  pmid    = {36626935},
  url     = {https://doi.org/10.1093/brain/awac399}
}

@article{vergallo2019-31113759,
  author  = {Vergallo, A. and Mégret, L. and Lista, S. and Cavedo, E. and Zetterberg, H. and Blennow, K. and Vanmechelen, E. and De Vos, A. and others},
  title   = {{Plasma amyloid β 40/42 ratio predicts cerebral amyloidosis in cognitively normal individuals at risk for Alzheimer's disease}},
  journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
  year    = {2019},
  doi     = {10.1016/j.jalz.2019.03.009},
  pmid    = {31113759},
  url     = {https://doi.org/10.1016/j.jalz.2019.03.009}
}

@article{saddiki2020-32817639,
  author  = {Saddiki, H. and Fayosse, A. and Cognat, E. and Sabia, S. and Engelborghs, S. and Wallon, D. and Alexopoulos, P. and Blennow, K. and others},
  title   = {{Age and the association between apolipoprotein E genotype and Alzheimer disease: A cerebrospinal fluid biomarker-based case-control study}},
  journal = {PLoS medicine},
  year    = {2020},
  doi     = {10.1371/journal.pmed.1003289},
  pmid    = {32817639},
  url     = {https://doi.org/10.1371/journal.pmed.1003289}
}

@article{blennow2006-16876668,
  author  = {Blennow, K. and de Leon, M. J. and Zetterberg, H.},
  title   = {{Alzheimer's disease}},
  journal = {Lancet (London, England)},
  year    = {2006},
  doi     = {10.1016/s0140-6736(06)69113-7},
  pmid    = {16876668},
  url     = {https://doi.org/10.1016/s0140-6736(06)69113-7}
}

@article{heslegrave2016-26754172,
  author  = {Heslegrave, A. and Heywood, W. and Paterson, R. and Magdalinou, N. and Svensson, J. and Johansson, P. and Öhrfelt, A. and Blennow, K. and others},
  title   = {{Increased cerebrospinal fluid soluble TREM2 concentration in Alzheimer's disease}},
  journal = {Molecular neurodegeneration},
  year    = {2016},
  doi     = {10.1186/s13024-016-0071-x},
  pmid    = {26754172},
  url     = {https://doi.org/10.1186/s13024-016-0071-x}
}

@article{salami2022-34924376,
  author  = {Salami, A. and Adolfsson, R. and Andersson, M. and Blennow, K. and Lundquist, A. and Adolfsson, A. N. and Schöll, M. and Zetterberg, H. and others},
  title   = {{Association of APOE ɛ4 and Plasma p-tau181 with Preclinical Alzheimer's Disease and Longitudinal Change in Hippocampus Function}},
  journal = {Journal of Alzheimer's disease : JAD},
  year    = {2022},
  doi     = {10.3233/jad-210673},
  pmid    = {34924376},
  url     = {https://doi.org/10.3233/jad-210673}
}

@article{frisoni2022-34815562,
  author  = {Frisoni, G. B. and Altomare, D. and Thal, D. R. and Ribaldi, F. and van der Kant, R. and Ossenkoppele, R. and Blennow, K. and Cummings, J. and others},
  title   = {{The probabilistic model of Alzheimer disease: the amyloid hypothesis revised}},
  journal = {Nature reviews. Neuroscience},
  year    = {2022},
  doi     = {10.1038/s41583-021-00533-w},
  pmid    = {34815562},
  url     = {https://doi.org/10.1038/s41583-021-00533-w}
}

@article{hulstaert1999-10331678,
  author  = {Hulstaert, F. and Blennow, K. and Ivanoiu, A. and Schoonderwaldt, H. C. and Riemenschneider, M. and De Deyn, P. P. and Bancher, C. and Cras, P. and others},
  title   = {{Improved discrimination of AD patients using beta-amyloid(1-42) and tau levels in CSF}},
  journal = {Neurology},
  year    = {1999},
  doi     = {10.1212/wnl.52.8.1555},
  pmid    = {10331678},
  url     = {https://doi.org/10.1212/wnl.52.8.1555}
}

@article{andreasen2001-11255440,
  author  = {Andreasen, N. and Minthon, L. and Davidsson, P. and Vanmechelen, E. and Vanderstichele, H. and Winblad, B. and Blennow, K.},
  title   = {{Evaluation of CSF-tau and CSF-Abeta42 as diagnostic markers for Alzheimer disease in clinical practice}},
  journal = {Archives of neurology},
  year    = {2001},
  doi     = {10.1001/archneur.58.3.373},
  pmid    = {11255440},
  url     = {https://doi.org/10.1001/archneur.58.3.373}
}

@article{ali2022-35617280,
  author  = {Ali, M. and Sung, Y. J. and Wang, F. and Fernández, M. V. and Morris, J. C. and Fagan, A. M. and Blennow, K. and Zetterberg, H. and others},
  title   = {{Leveraging large multi-center cohorts of Alzheimer disease endophenotypes to understand the role of Klotho heterozygosity on disease risk}},
  journal = {PloS one},
  year    = {2022},
  doi     = {10.1371/journal.pone.0267298},
  pmid    = {35617280},
  url     = {https://doi.org/10.1371/journal.pone.0267298}
}

@article{wallin2010-20458070,
  author  = {Wallin, A. K. and Blennow, K. and Zetterberg, H. and Londos, E. and Minthon, L. and Hansson, O.},
  title   = {{CSF biomarkers predict a more malignant outcome in Alzheimer disease}},
  journal = {Neurology},
  year    = {2010},
  doi     = {10.1212/wnl.0b013e3181dd4dd8},
  pmid    = {20458070},
  url     = {https://doi.org/10.1212/wnl.0b013e3181dd4dd8}
}

@article{voevodskaya2016-27164711,
  author  = {Voevodskaya, O. and Sundgren, P. C. and Strandberg, O. and Zetterberg, H. and Minthon, L. and Blennow, K. and Wahlund, L. O. and Westman, E. and others},
  title   = {{Myo-inositol changes precede amyloid pathology and relate to APOE genotype in Alzheimer disease}},
  journal = {Neurology},
  year    = {2016},
  doi     = {10.1212/wnl.0000000000002672},
  pmid    = {27164711},
  url     = {https://doi.org/10.1212/wnl.0000000000002672}
}

@article{prince2004-15184629,
  author  = {Prince, J. A. and Zetterberg, H. and Andreasen, N. and Marcusson, J. and Blennow, K.},
  title   = {{APOE epsilon4 allele is associated with reduced cerebrospinal fluid levels of Abeta42}},
  journal = {Neurology},
  year    = {2004},
  doi     = {10.1212/01.wnl.0000128088.08695.05},
  pmid    = {15184629},
  url     = {https://doi.org/10.1212/01.wnl.0000128088.08695.05}
}

@article{cavedo2020-31801830,
  author  = {Cavedo, E. and Lista, S. and Houot, M. and Vergallo, A. and Grothe, M. J. and Teipel, S. and Zetterberg, H. and Blennow, K. and others},
  title   = {{Plasma tau correlates with basal forebrain atrophy rates in people at risk for Alzheimer disease}},
  journal = {Neurology},
  year    = {2020},
  doi     = {10.1212/wnl.0000000000008696},
  pmid    = {31801830},
  url     = {https://doi.org/10.1212/wnl.0000000000008696}
}

@article{schultz2017-28341646,
  author  = {Schultz, S. A. and Boots, E. A. and Darst, B. F. and Zetterberg, H. and Blennow, K. and Edwards, D. F. and Koscik, R. L. and others},
  title   = {{Cardiorespiratory fitness alters the influence of a polygenic risk score on biomarkers of AD}},
  journal = {Neurology},
  year    = {2017},
  doi     = {10.1212/wnl.0000000000003862},
  pmid    = {28341646},
  url     = {https://doi.org/10.1212/wnl.0000000000003862}
}

@article{jauregizinkunegi2025-39783876,
  author  = {Jauregi-Zinkunegi, A. and Gleason, C. E. and Bendlin, B. and Okonkwo, O. and Hermann, B. P. and Blennow, K. and Zetterberg, H. and Hogervorst, E. and others},
  title   = {{Menopausal hormone therapy is associated with worse levels of Alzheimer's disease biomarkers in APOE ε4-carrying women: An observational study}},
  journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
  year    = {2025},
  doi     = {10.1002/alz.14456},
  pmid    = {39783876},
  url     = {https://doi.org/10.1002/alz.14456}
}

@article{saunders2022-36041266,
  author  = {Saunders, T. S. and Jenkins, N. and Blennow, K. and Ritchie, C. and Muniz-Terrera, G.},
  title   = {{Interactions between apolipoprotein E, sex, and amyloid-beta on cerebrospinal fluid p-tau levels in the European prevention of Alzheimer's dementia longitudinal cohort study (EPAD LCS)}},
  journal = {EBioMedicine},
  year    = {2022},
  doi     = {10.1016/j.ebiom.2022.104241},
  pmid    = {36041266},
  url     = {https://doi.org/10.1016/j.ebiom.2022.104241}
}

@article{ohrfelt2016-26754805,
  author  = {Öhrfelt, A. and Axelsson, M. and Malmeström, C. and Novakova, L. and Heslegrave, A. and Blennow, K. and Lycke, J. and Zetterberg, H.},
  title   = {{Soluble TREM-2 in cerebrospinal fluid from patients with multiple sclerosis treated with natalizumab or mitoxantrone}},
  journal = {Multiple sclerosis (Houndmills, Basingstoke, England)},
  year    = {2016},
  doi     = {10.1177/1352458515624558},
  pmid    = {26754805},
  url     = {https://doi.org/10.1177/1352458515624558}
}

@article{smith2023-36516028,
  author  = {Smith, R. and Cullen, N. C. and Pichet Binette, A. and Leuzy, A. and Blennow, K. and Zetterberg, H. and Klein, G. and Borroni, E. and others},
  title   = {{Tau-PET is superior to phospho-tau when predicting cognitive decline in symptomatic AD patients}},
  journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
  year    = {2023},
  doi     = {10.1002/alz.12875},
  pmid    = {36516028},
  url     = {https://doi.org/10.1002/alz.12875}
}

@article{ingala2021-33811742,
  author  = {Ingala, S. and De Boer, C. and Masselink, L. A. and Vergari, I. and Lorenzini, L. and Blennow, K. and Chételat, G. and Di Perri, C. and others},
  title   = {{Application of the ATN classification scheme in a population without dementia: Findings from the EPAD cohort}},
  journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
  year    = {2021},
  doi     = {10.1002/alz.12292},
  pmid    = {33811742},
  url     = {https://doi.org/10.1002/alz.12292}
}

@article{blom2009-19420940,
  author  = {Blom, E. S. and Giedraitis, V. and Zetterberg, H. and Fukumoto, H. and Blennow, K. and Hyman, B. T. and Irizarry, M. C. and Wahlund, L. O. and others},
  title   = {{Rapid progression from mild cognitive impairment to Alzheimer's disease in subjects with elevated levels of tau in cerebrospinal fluid and the APOE epsilon4/epsilon4 genotype}},
  journal = {Dementia and geriatric cognitive disorders},
  year    = {2009},
  doi     = {10.1159/000216841},
  pmid    = {19420940},
  url     = {https://doi.org/10.1159/000216841}
}

@article{lee2008-18703769,
  author  = {Lee, J. M. and Blennow, K. and Andreasen, N. and Laterza, O. and Modur, V. and Olander, J. and Gao, F. and Ohlendorf, M. and others},
  title   = {{The brain injury biomarker VLP-1 is increased in the cerebrospinal fluid of Alzheimer disease patients}},
  journal = {Clinical chemistry},
  year    = {2008},
  doi     = {10.1373/clinchem.2008.104497},
  pmid    = {18703769},
  url     = {https://doi.org/10.1373/clinchem.2008.104497}
}

@article{kettunen2015-25420549,
  author  = {Kettunen, P. and Larsson, S. and Holmgren, S. and Olsson, S. and Minthon, L. and Zetterberg, H. and Blennow, K. and Nilsson, S. and others},
  title   = {{Genetic variants of GSK3B are associated with biomarkers for Alzheimer's disease and cognitive function}},
  journal = {Journal of Alzheimer's disease : JAD},
  year    = {2015},
  doi     = {10.3233/jad-142025},
  pmid    = {25420549},
  url     = {https://doi.org/10.3233/jad-142025}
}

@article{slemmon2015-26332787,
  author  = {Slemmon, JR. and Shapiro, A. and Mercken, M. and Streffer, J. and Romano, G. and Andreasen, N. and Zetterberg, H. and Blennow, K.},
  title   = {{Impact of cerebrospinal fluid matrix on the detection of Alzheimer's disease with Aβ42 and influence of disease on the total-Aβ42/Aβ40 ratio}},
  journal = {Journal of neurochemistry},
  year    = {2015},
  doi     = {10.1111/jnc.13297},
  pmid    = {26332787},
  url     = {https://doi.org/10.1111/jnc.13297}
}

@article{masters2015-27188934,
  author  = {Masters, C. L. and Bateman, R. and Blennow, K. and Rowe, C. C. and Sperling, R. A. and Cummings, J. L.},
  title   = {{Alzheimer's disease}},
  journal = {Nature reviews. Disease primers},
  year    = {2015},
  doi     = {10.1038/nrdp.2015.56},
  pmid    = {27188934},
  url     = {https://doi.org/10.1038/nrdp.2015.56}
}

@article{lista2015-26401553,
  author  = {Lista, S. and O'Bryant, S. E. and Blennow, K. and Dubois, B. and Hugon, J. and Zetterberg, H. and Hampel, H.},
  title   = {{Biomarkers in Sporadic and Familial Alzheimer's Disease}},
  journal = {Journal of Alzheimer's disease : JAD},
  year    = {2015},
  doi     = {10.3233/jad-143006},
  pmid    = {26401553},
  url     = {https://doi.org/10.3233/jad-143006}
}

@article{sjolander2010-20849576,
  author  = {Sjölander, A. and Zetterberg, H. and Andreasson, U. and Minthon, L. and Blennow, K.},
  title   = {{BACE1 gene variants do not influence BACE1 activity, levels of APP or Aβ isoforms in CSF in Alzheimer's disease}},
  journal = {Molecular neurodegeneration},
  year    = {2010},
  doi     = {10.1186/1750-1326-5-37},
  pmid    = {20849576},
  url     = {https://doi.org/10.1186/1750-1326-5-37}
}